Dr. Steven Gerard Achinger, MD

Dr. Achinger practices at DaVita Lake Vista Dialysis in Lakeland, Florida.

Dr. Achinger's NPI, 1073514386, was assigned on August 9, 2005. Dr. Achinger graduated from University of Miami, Miller School of Medicine in 2000. Dr. Achinger holds Florida license ME104616.

Dr. Achinger's primary practice is DaVita Lake Vista Dialysis, at 3187 Us Hwy 98 N, Lakeland, FL 33805 in Polk County. The practice phone is (863) 603-2130.

Dr. Achinger's primary practice is DaVita Lake Vista Dialysis in Lakeland, Florida. Dr. Achinger is also affiliated with Lakeland Regional Health Medical Center. The medical group on file is Watson Clinic. Dmand AI also links Dr. Achinger to 4 more dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Achinger practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Achinger's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Achinger is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Achinger's licenses on file in 2 states: Florida and Texas.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia and kidney cysts among the conditions Dr. Achinger treats.

CMS data shows 3,713 Medicare services from Dr. Achinger across 13 procedure codes in 2024, for 738 Medicare patients. Medicare paid $246,578 for them.

CMS counts 738 Medicare patients who saw Dr. Achinger in 2024. The largest group is 75 to 84, with 291 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 15% are also on Medicaid. Their average risk score is 3.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Achinger's median patient age at 76, with 46% women.

In 2024, Dr. Achinger wrote 3,359 Medicare Part D claims for 634 patients. 87% of them were for generic drugs. CMS names the drug for 3,005 of them, across 39 drugs with 11 or more claims each, at $352,122 in total drug cost. In 2023, CMS named 2,856 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Achinger for performance year 2024, reported through an alternative payment model (APM). Dr. Achinger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Achinger as offering telehealth.

Dmand AI links 23 papers to Dr. Achinger, published from 2006 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Renal Dialysis, Kidney Failure, Chronic and Hypertrophy, Left Ventricular. Dr. Achinger has published most often in Hemodial Int. Dr. Achinger's most frequent co-authors are Alan S. Go, MD, Glenn Matthew Chertow, MD and Wieslaw B. Furmaga, MD.

CMS Open Payments shows 13 general payments to Dr. Achinger from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $182.

Dr. Achinger graduated from University of Miami, Miller School of Medicine in 2000.

Dr. Achinger is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.